SEARCH

MENU

Current Edition

Alport syndrome

FDA panel turns down Reata kidney disease drug in unanimous vote

The company’s shares plummeted by more than 40% in early Thursday trading after taking a hit earlier in the week when the FDA released the …

10 December 2021 Alport syndrome Drug

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte LTD